ALLISON MURPHY: Open Payments
NPI 1235656513 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,428 in 76 payments from 19 companies in 2025. Trend: 2023 $980 · 2024 $904 · 2025 $1,428
Food & beverage: $1,428
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 20 | $307 |
| Merck Sharp & Dohme LLC | 10 | $176 |
| AstraZeneca Pharmaceuticals LP | 8 | $141 |
| ABBVIE INC. | 2 | $137 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Agios Pharmaceuticals, Inc. | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 5 | $83 |
| Janssen Biotech, Inc. | 4 | $69 |
| Astellas Pharma US Inc | 3 | $60 |
| Eisai Inc. | 3 | $52 |
Products named: Enhertu, KEYTRUDA, ELAHERE, PYRUKYND, LYNPARZA, TALVEY, Lenvima, DATROWAY.
Industry payments across NJ — which companies pay providers there.
